Belvedere Trading
ADVM

Belvedere Trading’s Adverum Biotechnologies ADVM Stock Holding History

Belvedere Trading’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,900
Closed -$11.7K – 712
2024
Q2 		$11.7K Buy
+16,900
New +$157K ﹤0.01% 586
2023
Q1 		– Sell
-950
Closed -$5.51K – 887
2022
Q4 		$5.51K Buy
+950
New +$7.2K ﹤0.01% 974
2022
Q1 		– Sell
-8,480
Closed -$131K – 450
2021
Q4 		$131K Sell
8,480
-10,820
-56% -$217K 0.01% 262
2021
Q3 		$390K Buy
19,300
+14,200
+278% +$362K 0.01% 139
2021
Q2 		$159K Buy
+5,100
New +$275K 0.01% 221

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return